Dermatology companies develop therapeutics, diagnostics and research technologies for conditions affecting the skin, hair and nails. Their work supports the detection, treatment and management of inflammatory, infectious, autoimmune and chronic skin disorders.
This category includes companies working on:
Browse 24 UK dermatology companies below.
Small molecule drug discovery targeting rare genetic diseases and oncology
Tay Therapeutics is a drug discovery company developing targeted small molecule therapies for rare genetic diseases and cancer. Its platform uses stop codon read-through technology to restore production of functional proteins disrupted by premature stop codon mutations, with programmes targeting oncology, cystic…
One-step encapsulation drug delivery platform for advanced therapeutics
PNAS Therapeutics is a UK-based drug delivery company developing a one-step encapsulation platform designed to simplify complex pharmaceutical manufacturing processes. The platform enhances local delivery through improved bioavailability and targeting, is compatible with multiple active pharmaceutical ingredients, and…
Preventing cancer therapy side effects with topical medicines
VasoDynamics is a clinical-stage pharmaceutical development company focused on preventing the debilitating side effects of cancer therapy. The company develops topical formulations targeting radiation-induced oral mucositis, dermatitis, and chemotherapy-induced hair loss, using vasoconstrictor and radioprotective…
Immunometabolism-targeting small molecules for autoimmune disease
Sitryx Therapeutics is a clinical-stage biopharmaceutical company developing oral small molecule therapeutics that modulate immune cell metabolism to achieve disease remission in autoimmune and inflammatory conditions. The company's approach targets novel metabolic enzymes within immune cells, with lead programmes in…
Diagnostic reagents, allergy testing products and contract diagnostics manufacturing
Bio-Diagnostics is a manufacturer of diagnostic products and provider of contract services for the in vitro diagnostics industry. Its own range covers reagents and tests for infectious disease, autoimmunity and immunohistochemistry, alongside an extensive portfolio of allergens and accessories for patch and skin prick…
Topical peptide therapeutics targeting inflammatory skin disease
Carocell Bio is a pre-clinical stage biotechnology company developing proprietary peptide-based therapeutics for inflammatory diseases. Its pipeline centres on topical formulations that inhibit mitogen-activated protein kinase (MAPK/p38), a key regulator of the inflammatory cascade. Lead programmes target atopic…
Tension-preserved human skin models for dermatology and drug testing
Ten Bio is a contract research organisation providing physiologically tensioned human skin models for pharmaceutical, dermatology and cosmetic research. Its patented TenSkin platform maintains full-thickness, ethically sourced surgical skin with its barrier, appendages and minor cell populations, preserving functional…
Non-invasive skin epigenomics platform for clinical and cosmetic research
Mitra Bio is a contract research organisation providing a non-invasive skin epigenomics platform to pharmaceutical and cosmetic companies conducting clinical trials on dermatological and age-reversal interventions. Using tape-strip skin sampling combined with whole-genome DNA methylation sequencing and bioinformatic…
Clinical skin microbiome testing and multi-omic ingredient analysis platform
Sequential Skin is a biotechnology company providing non-invasive clinical microbiome testing and multi-omic analysis services to the personal care and pharmaceutical industries. Using patch-based sampling and next-generation sequencing, the company quantifies how ingredients and formulations affect the skin…
Small molecule therapies for keratin-related skin disorders
Mariposa Therapeutics is a Welsh preclinical biopharma company developing disease-modifying treatments for epidermolysis bullosa simplex and other keratin-related skin disorders. Its lead compound, MP5219, is a synthetic analogue of ajoene that activates surrogate keratin expression to compensate for the underlying…
Steroid-free dermatology formulations and investigational GL-1 platform
Gran Lab is a Queen's University Belfast spin-out developing biochemical formulations for inflammatory and reactive skin conditions. Its investigational GL-1 topical platform is being developed as a non-steroidal approach to psoriasis and related dermatoses, with laboratory studies ongoing and clinical trials in…
AI-driven skin microbiome platform for skincare and drug discovery
Biotix is a biotechnology company applying artificial intelligence and microbiome science to discover and develop novel approaches for skin health. Its AI platform analyses proprietary microbiome and clinical datasets to identify beneficial skin microbes and their metabolites, supporting both a commercial skincare…
Non-invasive mitochondrial DNA damage testing for skin health research
Skin Life Analytics is a biotechnology company providing PCR-based testing services that quantify mitochondrial DNA damage in skin using non-invasive swab sampling. The technology detects molecular markers of skin ageing, UV damage, and environmental stress before visible signs appear. Services include direct testing…
Virus-like particle therapeutics for chronic inflammatory skin conditions
Glen Clova Scientific is a biotechnology company developing active biologic drugs for chronic inflammatory and autoimmune disorders, with an initial focus on immuno-dermatology. Its proprietary virus-like particle platform is designed to induce targeted immune responses against self-produced proteins that drive…
Novel antibiotic-sparing therapeutics for chronic wound care
ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented controlled-release drug delivery technology designed to manage wound exudate and reduce reliance on antibiotics, addressing antimicrobial resistance in…
Allogeneic neutrophil cell therapy platform for solid tumours
LIfT BioSciences is a biotechnology company developing a first-in-class allogeneic neutrophil immunotherapy for the treatment of solid tumours. Its platform produces Immuno-Modulatory Alpha Neutrophils (IMANs) from donor haematopoietic or induced pluripotent stem cells using a proprietary enhancement process. IMANs…
AI-assisted bioactive ingredient discovery and laboratory formulation testing
HexisLab is a research and development company providing ingredient discovery, laboratory testing and formulation services for personal care and consumer health businesses. Its HexisPro.X platform uses computational screening to identify candidate bioactive compounds, peptides and sustainable ingredient alternatives.…
Human skin explant CRO for immunotoxicity and drug safety testing
Alcyomics is a contract research organisation providing non-animal, human-based in vitro safety and efficacy testing services to pharmaceutical, biotechnology, and cosmetics clients. Its core assay technology uses non-artificial human skin explants to predict adverse immune reactions, including cytokine storm and skin…
Asymmetric biomaterial skin substitutes for acute and chronic wounds
Janus Biosciences is a biotech developing novel biomaterial skin substitutes for the treatment of acute and chronic wounds. The platform is based on asymmetric Janus material architectures, in which opposing faces of the scaffold present distinct physicochemical properties to simultaneously support wound bed healing…
Lab-grown human skin equivalent for cosmetic and pharmaceutical testing
Labskin is a contract research organisation offering preclinical testing services built around a proprietary full-thickness, lab-grown human skin equivalent. The model incorporates primary human keratinocytes and fibroblasts and is uniquely capable of hosting the skin's natural microflora, enabling microbiome-relevant…